Experimental lymphedema drug reduces swelling in clinical trials in new hope for patients

Scientists have inched a step closer to developing a first-of-its-kind drug to treat lymphedema, a chronic swelling condition that affects 10 million Americans.
Fire or Trash?
Your verdict on this story. One tap, no account needed.Dumpster Fire links to reporting from Daily Mail. We don’t rewrite the facts; the original story is one click away.
Comments
Loading comments…
Comments are automatically checked for hate, threats and spam. Community rules.